Fundraising FoxEntasistx
1 known investors
Find your way into Entasistx
Sign up to find every way you can get introduced to Entasistx
- Your email: who you already know at Entasistx, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Entasistx team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Entasis Therapeutics is a biotechnology company developing and marketing therapies for critical care and infectious diseases, focusing on serious conditions with high unmet need. Its products include GIAPREZA, NUZOLVENCE, XACDURO, XERAVA, and ZEVTERA.
Investors · 1
Sofinnova Ventureslisted by Sofinnova VenturesMenlo Park · $100K – $15M
How we know: Sofinnova Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Entasistx do?
- Entasis Therapeutics is a biotechnology company developing and marketing therapies for critical care and infectious diseases, focusing on serious conditions with high unmet need. Its products include GIAPREZA, NUZOLVENCE, XACDURO, XERAVA, and ZEVTERA.
- Who are Entasistx's investors?
- Entasistx's investors include Sofinnova Ventures.